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Abstract: Staphylococcus aureus is the most common contagious pathogen associated with bovine
subclinical mastitis. Current diagnosis of S. aureus mastitis is based on bacteriological culture of
milk samples and somatic cell counts, which lack either sensitivity or specificity. Identification of
milk proteins that contribute to host defense and their variable responses to pathogenic stimuli
would enable the characterization of putative biomarkers of subclinical mastitis. To accomplish
this, milk whey samples from healthy and mastitic dairy cows were analyzed using a label-free
quantitative proteomics approach. In total, 90 proteins were identified, of which 25 showed significant
differential abundance between healthy and mastitic samples. In silico functional analyses indicated
the involvement of the differentially abundant proteins in biological mechanisms and signaling
pathways related to host defense including pathogen-recognition, direct antimicrobial function,
and the acute-phase response. This proteomics and bioinformatics analysis not only facilitates the
identification of putative biomarkers of S. aureus subclinical mastitis but also recapitulates previous
findings demonstrating the abundance of host defense proteins in intramammary infection. All mass
spectrometry data are available via ProteomeXchange with identifier PXD007516.
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1. Introduction
Bovine mastitis is most often caused by a bacterial infection and results in severe losses in milk
production and in the deterioration of the physical and chemical composition of the milk [1,2]. Mastitis
is estimated to cost the Canadian dairy industry more than $300 million annually [3]. This has a huge
economic impact on the dairy industry as well as concerns of zoonotic disease transmission and
contributions to the emergence of antimicrobial resistance [4]. Clinical mastitis is usually associated
with visible local and systemic signs of inflammation of the udder and with abnormalities in the
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secreted milk such as watery consistency, milk clots, flakes, or evidence of blood or pus. In contrast,
subclinical mastitis (SCM) lacks recognizable inflammatory manifestations, so the infected animals
can go undetected, and the infection might advance to a chronic stage resulting in unresponsiveness
to treatment. Staphylococcus aureus is one of the most frequently isolated bacterial pathogens from
persistent subclinical mastitis cases [1,4]. In Canada, herd level prevalence ranges from 40% in British
Columbia, 60% in Alberta, ~70% in Ontario and Quebec, and up to 90% in Saskatchewan and Nova
Scotia [5]. Currently, there are only limited diagnostic tests performed on milk to detect subclinical
intramammary infection (IMI) due to S. aureus, and those that are available have moderate specificity
and sensitivity [6,7]. Therefore, there is a critical need to develop tests that detect the early stage of
subclinical mastitis, allowing for efficient treatment of diseased cows and thereby minimizing the
spread of the infection throughout the herd.
Host–pathogen interactions are variable during the different stages of mastitis and are important
determinants of the outcome of the infection [8,9]. Indeed, the outcome—either elimination of
the pathogen from the mammary glands or establishment of the infection—is strongly dependent
on the host immune response [10,11]. If bacteria gain access to mammary tissues by evading the
teat anatomical barriers, a typical first line of host defense is the activation of the innate immune
response either by recognition of pathogen molecules or by upregulation of the local resident immune
components within the mammary tissues. Changes in the abundance levels of innate immune
mediators and modulation in their abundance patterns could act as biomarkers of the host response to
predict early intramammary infection with specific pathogens [12–14].
Recent advances in proteomic technologies, together with rapidly evolving bioinformatics tools,
allows for in-depth analyses of different fractions of the milk proteome, especially the low-abundant
proteins [15–17]. Accordingly, the aim of this study was to profile and quantify the differential
abundance of milk whey proteins in cows with subclinical mastitis naturally infected with S. aureus
compared with that in healthy control animals. S. aureus was chosen in order to reduce confounding
factors that might arise as a result of examination of subclinical mastitis due to a variety of different
pathogens. In the present study, a proteomic approach involving liquid chromatography and tandem
mass spectrometry was applied to whey samples to identify potential biomarker proteins of subclinical
mastitis. Furthermore, the biological relevance of the differentially abundant proteins in subclinical
mastitis was investigated using various bioinformatics strategies to connect proteins to known
biological functions and pathways.
2. Results
Shotgun proteomic analyses of bovine milk whey proteins involving trypsin digestion, separation
of peptides by liquid chromatography (LC) coupled to MS/MS, and label-free proteomic analyses
revealed modulation of the milk proteome in cows infected with S. aureus and differential abundance
of proteins with host defense functions. A MaxQuant software-based search against the Bos taurus
proteome database resulted in the identification of 90 proteins (Table S1), among which 25 proteins
were differentially abundant between the control and mastitic groups. Fifteen proteins were identified
with high abundance, whereas ten were identified with low abundance in comparison with the control
group Table 1. The hierarchical clustering analysis of the identified proteins (Figure 1) revealed two
different clusters—one each for control and mastitis samples. One of the diseased samples (D6) was
excluded from the clustering analysis due to a weak peptides signal compared with the other replicates.
Gene Ontology (GO) enrichment analysis using Database for Annotation, Visualization, and
Integrated Discovery (DAVID) software revealed several categories related to host defense, the most
relevant of which are as follows: 29.1% of identified proteins were associated with “response to
bacterium” (GO:0009617), 25% with “regulation of cytokine production” (GO:0001817), 20.8% with
the “innate immune response” (GO:0045087), 12.5% with the “toll-like receptor signaling pathway”
(GO:0002224), and 8.3% with “cellular response to lipoteichoic acid” (GO:0071223). The complete list
of the GO terms that were enriched in the analysis is provided in Table S2. The most relevant GO
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biological processes in which the proteins were annotated are shown in Table 2. The direct GO option
of DAVID was used at p < 0.05.
Table 1. Proteins significantly high-abundant or low-abundant by the presence of Staphylococcus aureus







Q8SPP7 Peptidoglycan recognition protein 1 7.92 (+) 0.000 10
Q2TBU0 Haptoglobin 6.45 0.002 17
Q3ZBX9 Histone H2A.J 5.47 0.000 1
P63258 Actin, cytoplasmic 2 5.46 0.002 9
E1B6Z6 Neutrophil gelatinase-associated lipocalin 5.29 0.001 13
P10096 Glyceraldehyde-3-phosphate dehydrogenase 5.17 0.003 8
Q1JPB0 Leukocyte elastase inhibitor (Serpin B1) 4.31 0.003 7
P33046 Cathelicidin-4 (Indolicidin) 4.29 0.002 4
G3X807 Histone H4 4.09 0.003 6
F1MYX5 Uncharacterized protein 4.08 0.002 13
P30922 Chitinase-3-like protein 1 3.97 0.01 16
G3MXB5 Uncharacterized protein 2.70 0.002 5
Q2TBI0 Lipopolysaccharide-binding protein 2.69 0.014 12
P07688 Cathepsin B 2.31 0.011 9
P24627 Lactotransferrin (Lactoferrin) 2.28 0.001 61
P79345 Epididymal secretory protein E1 −0.70 (−) 0.013 9
P08037 Beta-1,4-galactosyltransferase 1 −1.08 0.011 12
Q9TUM6 Perilipin-2 (Adipophilin) −1.55 0.006 18
P11151 Lipoprotein lipase −1.57 0.007 13
Q95122 Monocyte differentiation antigen CD14 −1.70 0.00 9
Q0P569 Nucleobindin-1 −1.84 0.014 15
P80025 Lactoperoxidase −1.93 0.001 31
G5E5H7 Uncharacterized protein −2.18 0.009 3
Q4GZT4 ATP-binding cassette sub-family G member 2 −2.33 0.004 12
Q9XSG3 Isocitrate dehydrogenase −2.92 0.013 10
(+) high-abundant proteins and (−) low-abundant proteins were present at significantly higher or lower levels,
respectively, in mastitic cows compared with the healthy control cows.
Table 2. Biological processes (BP) that were significantly enriched in differentially abundant proteins
during S. aureus mastitis.
GO Terms (Biological Processes) * Gene Name p-Value
GO:0042742~defense response to bacterium Hp, LPO, CATHL4 0.0066
GO:0031640~killing of cells of other organism PGLYRP1, CATHL4 0.0076
GO:0071223~cellular response to lipoteichoic acid LBP, CD14, PGLYRP1 0.0091
GO:0034145~positive regulation of Toll-like receptor 4 signaling pathway LTF, LBP 0.0136
GO:0006953~acute-phase response Hp, LBP 0.027
GO:0019731~antibacterial humoral response LTF, LPO 0.0314
GO:0031663~lipopolysaccharide-mediated signaling pathway LBP, CD14 0.0417
GO:0045087~innate immune response LBP, CD14, PGLYRP1 0.0459
GO:0098869~cellular oxidant detoxification Hp, LPO 0.0461
* Gene ontology (GO) biological processes (BP) terms when direct option was used in the Database for
Annotation, Visualization, and Integrated Discovery (DAVID) are indicated to avoid the redundancy of the
terms enriched at p < 0.05 and 5% false discovery rate (FDR). LBP = Lipopolysaccharide-binding protein,
CD14 = Monocyte differentiation antigen, LTF = Lactotransferrin, CATHL4 = Cathelicidin-4, Hp = Haptoglobin,
(PGLYRP1) = Peptidoglycan recognition protein 1, LPO = Lactoperoxidase.
Protein–protein interaction (PPI) was investigated using the Search Tool for the Retrieval of
Interacting Genes/Proteins (STRING) database. Twelve proteins were enriched in networks, each one
representing nodes of which nine proteins showed interactions reflected by connecting lines or edges
(Figure 2). The confidence score of the interaction networks ranged from 0.526 to 0.951. The higher
confidence score reflects the higher probability that the interaction is biologically meaningful given that it
is supported by several types of evidence such as curated databases, or was experimentally determined.
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Figure 1. Heat map representing the hierarchical clustering analysis of the identified proteins and the
proteins that were significantly high-/low-abundant in the mastitic group compared with the control
group. Data analysis was based on label-free quantification (LFQ) and was performed in Perseus
software using five biological replicates of both control and mastitic groups. Columns represent
samples; rows are individual proteins. Red indicates high-abundant proteins and green indicates
low-abundant proteins. UniProt ID numbers are indicated on the right.
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Figure 2. The protein–protein interaction network analysis using Search Tool for the Retrieval of
Interacting Genes/Proteins (STRING) software. The nodes represent individual proteins enriched
in the analysis and the edges (connecting lines) reflect the functional associations derived from
various online resources. Pr tein nodes which are enlarged indicate the availability of 3D protein
structure information. LBP = Lipopolysaccharide-binding protein, CD14 = Monocyte differentiation
antigen, H4 = Histo e, H2AFJ = Histon H2A, LTF = Lactotransferrin, CATHL4 = Cathelicidin-4,
HP = Haptoglobin, IDH1 = Isocitrate dehydrogenase, ABCG2 = ATP-binding cassette subfamily G
member 2, GAPDH = Glyceraldehyde-3-phosphate dehydrogenase, ACTG1 = Actin cytoplasmic 2, and
LCP1 = Uncharacterized protein.
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Twenty-three differentially abundant proteins were found to be enriched in most of the Canonical
pathways and network analyses performed using Ingenuity Pathway Analysis (IPA). As shown in
Figure 3, many of the enriched pathways reflect the involvement of proteins with host defense
functions such as the Toll-like Receptor Signaling pathway in which lipopolysaccharide-binding
protein (LBP) and monocyte differentiation antigen (CD14) were enriched. Similarly, haptoglobin (Hp)
and lactotransferrin (LTF) were enriched in the acute-phase response. Additionally, the differentially
abundant proteins in our dataset were enriched in vitamin D receptor/ retinoid X receptor (VDR/RXR)
activation, liver X receptor/retinoid X receptor (LXR/RXR) activation, inducible nitric oxide synthase
(iNOS) signaling, interleukin-6 (IL-6) signaling and acute-phase response signaling.
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Figure 3. Ingenuity-based identification of key signaling canonical pathways enriched in proteins
in milk infected with S. aureus. Each pathway is represented with a bar, the length of which shows
the negative log of the p-value obtained by a Right Tailed Fisher’s Exact Test (the longer the bar,
the more significant the enrichment) and the color reflects available information on the activity pattern
(i.e., protein abundance). White bars: Z-score = 0 indicates protein abundance is enriched in the
pathway (i.e., either high-abundant or low-abundant); grey bars: indicate that no activity pattern is
available in the software database. Ratio indicates the proportion of differentially abundant proteins
found in the current dataset relative to the total number of proteins contributing to that pathway
(e.g., a ratio of 0.2 indicates that 20% of the proteins in the pathway were identified in the dataset).
VDR/RXR = Vitamin D receptor, RXR = retinoid X receptor, LXR = liver X receptor, RXR = retinoid X
receptor, NOS = nitric oxide synthase, IL = interleukin.
3. Discussion
The objective of the present study was to characterize the changes of the bovine milk whey
proteome during S. aureus subclinical mastitis and to identify proteins that represent potential
candidate biomarkers. The long-term goal is to validate key biomarker proteins in future studies
and to eventually develop a diagnostic tool with improved sensitivity and specificity for subclinical
mastitis. The LC/MS-based label-free quantitative proteomic analysis of milk whey samples from
healthy and mastitic animals revealed a significant overabundance of proteins in mastitic milk. Of the
90 proteins identified, 25 are involved in well-characterized host defense functions or inflammatory
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processes. This suggests that infection with S. aureus is associated with a host immune response that
is reflected at the level of the milk proteome. In contrast to other studies [16–18] that characterized
altered protein levels during experimental S. aureus mastitis, our study investigated these alterations
in samples collected from cows naturally infected with S. aureus. Collecting field data from naturally
infected cows has the advantage of avoiding experimental design difficulties in terms of challenge
levels and exposure probabilities; however, cows may be represented at various stages of progression
of subclinical intramammary infection [19]. Furthermore, in the present study, preparation of milk
samples by initial skimming and low speed centrifugation may have removed some proteins that
might have been identified by other studies where pretreatment of milk samples was less extensive.
Identification of protein repertoires in the milk of cows affected by spontaneous mastitis is
an appropriate and valuable strategy for discovery of potential biomarkers to be used in novel
diagnostic tests with increased accuracy for subclinical mastitis. Bioinformatics analysis revealed
that several differentially abundant proteins listed in Table 2 can be divided into subcategories of
host defense biological functions. Haptoglobin (Hp) and lipopolysaccharide-binding protein (LBP)
function as acute-phase proteins, while cathelicidin-4 (CATHL4), peptidoglycan recognition protein1
(PGLYRP1), lactoperoxidase (LPO), lactotransferrin (Lactoferrin) (LTF), histone proteins (histone
H4 and Histone H2A), and cathepsin B (CTSB) have known antimicrobial activity. A third group
functions as pathogen-recognition proteins including lipopolysaccharide-binding protein (LBP),
monocyte differentiation antigen (CD14), and chitinase-3-like protein 1 (CHI3L1). Other differentially
abundant proteins have known metabolic or structural functions such as lipoprotein lipase (LPL),
beta-1,4-galactosyltransferase 1 (B4GALT1), glyceraldehyde-3-phosphate dehydrogenase (GAPDH),
nucleobindin-1 (NUCB1), and Actin (ACTG). In the mammary glands, the immune response to
different pathogens, including S. aureus, is a reflection of the inherent capability of the innate immune
system to induce an integrative reaction to recognize, minimize, and overcome intramammary
infection. This response starts with recognizing the highly conserved motifs which are known as
pathogen-associated molecular patterns (PAMPs), such as lipoteichoic acid (LTA), peptidoglycan
(PGN), or lipopolysaccharide (LPS). These are major components of the outer cell wall of gram-positive
and gram-negative bacteria, respectively [11,20,21]. The recognition of PAMPs occurs through
pattern recognition receptors (PRRs) which include the family of Toll-like receptors (TLRs) that can
recognize specific PAMPs. Additionally, LBP also plays an important role in recognizing bacterial
LPS and LTA during E. coli and S. aureus mastitis [11,22]. LBP delivers and facilitates the binding
of bacterial LPS or PGN to membrane-bound CD14 (mCD14) or soluble CD14 (sCD14) to form
a LBP–LPS–mCD14 complex. This complex is then recognized by TLR4 to induce an innate immune
response to infection initiated by LPS or gram-negative bacteria. However, interaction of LBP with
LTA or PGN of gram-positive bacteria and subsequent binding to mCD14 triggers a different innate
immune response via TLR2 activation [23,24]. Results from our PPI network analysis highlighted
the functional interaction between LBP and CD14 with a high confidence score (0.9). Moreover,
GO analysis highlighted their involvement in biological processes relevant to the innate immune
response such as “cellular response to LTA” (GO:0071223), “pattern recognition receptor signaling
pathway” (GO:0002221), and “positive regulation of cytokine production” (GO:0001819). Therefore, the
observation that LBP was high-abundant in this study is consistent with its known immune activities
as one of the key host defense mechanisms that control intramammary infection. However, we found
that that CD14 was low-abundant, which is in contrast to a previous study in mastitic cows which
reported elevated levels of CD14 either in serum or milk whey following intramammary infection with
S. aureus [20]. Nonetheless, our observation is in agreement with another study which investigated
the levels of CD14 in S. aureus or S. uberis bovine mastitic milk postpartum and concluded that low
levels of CD14-positive cells might be an indicator of mastitis following calving [25]. LBP protein also
plays an important role as a major positive acute-phase protein which is synthesized in the liver and
released into the general circulation and is produced locally in the mammary glands in response to the
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induction of pro-inflammatory cytokines such as IL-1 and IL-6 [26,27]. LBP was one of the proteins
identified in the IL-6 signaling pathway in the Ingenuity pathway analysis.
Haptoglobin (HP) is another positive acute-phase protein that was high-abundant in mastitic
milk in our study. Several studies demonstrated that Hp is a sensitive marker of mastitis, especially
when measured in milk, rather than in serum, with increases in excess of 100-fold during earlier stages
of intramammary infection (IMI) [28,29]. Moreover, Hp was high-abundant during acute mastitis
caused by three different strains of S. aureus [17] or E. coli [26], suggesting that Hp is a sensitive
nonspecific indicator of inflammation as it cannot discriminate between different pathogens. The main
biological role of Hp is to bind to free hemoglobin-derived iron to render it unavailable to bacteria,
resulting in a bacteriostatic effect, reducing bacterial growth and multiplication [22,29,30]. Following
IMI, macrophages produce pro-inflammatory cytokines—predominantly IL-6, IL-1, and tumor necrosis
factor alpha (TNFα)—that elicit an acute-phase response which stimulates the synthesis of Hp in the
liver and locally in the mammary gland tissues. The other possible sources of Hp in milk during
mastitis are somatic cells, predominantly neutrophils, or via leakage through the damaged blood–milk
barrier [29,31]. Enrichment of Hp in the IL-6 signaling pathway in the IPA analysis in our dataset is
consistent with the role that IL-6 plays in activation of the acute-phase response during inflammation,
as was shown in previous studies.
Another group of host defense-related proteins identified in our study are diverse proteins with
direct antimicrobial functions, produced by neutrophils and macrophages, that infiltrate the mammary
glands in response to IMI or are synthesized locally by mammary epithelial cells [11,32–34]. Among
this group of proteins, LTF, CATHL4, PGLYRP1, CTSB, H4, and H2A were high-abundant; however,
LPO was low-abundant in mastitic whey milk compared with that of controls. LTF is recognized
as an antimicrobial and bactericidal protein through its capacity to sequester Fe which deprives the
bacteria of this critical element required for growth and replication. The levels and patterns of the LTF
protein during clinical or subclinical mastitis were investigated in earlier studies that found LTF to be
significantly increased in milk from quarters infected with S. aureus or Streptococcus agalactiae [35,36].
Similarly, another study suggested that levels of LTF protein are pathogen-specific as a significant
abundance of LTF occurred during S. uberis, whereas S. aureus and E. coli IMI induced low levels of
LTF during IMI [35]. LTF was identified and validated in a recent study as a putative diagnostic and
prognostic biomarker for cows with high resistance to mastitis and other metabolic diseases versus
low-resistance cows [37]. GO analysis showed enrichment of LTF in relevant biological processes
such as “antibacterial humoral response” (GO:0019731) and “positive regulation of innate immune
response” (GO:0045089). Moreover, the protein–protein interaction network analysis in the present
study showed the well-known functional interaction between Hp and LTF in chelating free iron, which
affects the growth of many pathogens.
CATHL4 is a member of ten cathelicidin genes that have previously been identified in bovine milk
which are produced or secreted from neutrophil cytoplasmic granules and have well-characterized potent
antimicrobial functions and proinflammatory activities [38,39]. Our results indicating high-abundance
of CATHL4 in milk from cows infected with S. aureus subclinical mastitis concur with other proteomic
studies [13,15,16,40]. An advantage of measuring CATHL4 as an inflammatory marker is that it can
be detected in mastitic milk only and not in the milk of healthy animals [40,41]. The protein–protein
interaction network analysis showed the well-characterized interaction between LTF and CATHL4,
suggesting their dual protective role as AMP and key components of the innate arm of the immune system.
In the current study, peptidoglycan recognition protein-1 (PGLYRP1) showed the highest increase
(eightfold) of all differentially abundant proteins in mastitic milk. PGLYRP1 is a conserved pattern
recognition molecule, found mainly in polymorphonuclear leukocyte granules, that recognizes bacterial
peptidoglycan and is bactericidal by way of inhibiting peptidoglycan synthesis [15,42]. LPO is known
to exert antimicrobial effects and was previously reported as a biomarker of mastitis due to its role
as an innate immune effector molecule. However, LPO was low-abundant in the current analysis of
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mastitic milk which may suggest that levels are decreased or limited by the low oxygen tension in the
milk, as reported in previous studies of IMI with S. uberis and S. aureus [11,43,44].
Histone proteins (H4 and H2A) were detected in higher abundance in mastitic milk in the
current analysis, which might reflect their well-characterized antimicrobial functions shown in earlier
studies [45]. Indeed, a recent study revealed that histone proteins are one of the main components of
neutrophil extracellular traps (NETs) produced in milk during mastitis [16,46,47]. NETs are considered
to be a unique mechanism adopted by the neutrophils to limit and kill the invading bacteria through
the production of a web of DNA, histones, and other antimicrobial proteins to trap and destroy
bacteria [48,49]. The abundance of histone proteins in the mastitic whey in our analysis could be
possibly due to their release as a result of cell lysis as well as NET disintegration [16].
The magnitude and the pattern/quantitative trends of the proteins present in mastitic milk
compared to milk from healthy animals reflect the ability of S. aureus to modulate the host response
as reported in other studies [16,20,50]. However, the complex nature and the high dynamic range of
the milk proteome, the fractionation of whey proteins during sample preparation, and the dynamic
exclusion of casein during MS analysis limited the number of low-abundant proteins that were
identified. Additionally, the inherent biological variability of the immune response in infected cows
during naturally occurring mastitis contributed to the inconsistent abundance of the identified proteins.
However, taken together, our data suggest that high-abundance of host defense-related proteins
represents modulation of the milk proteome during IMI with S. aureus. Quantitative proteomics using
label-free analysis enabled the detection of proteomic signatures that reflect the host response in bovine
subclinical mastitis and provided a comprehensive identification of proteins of low abundance in
a broad molecular weight range that is typically missed with conventional gel-based approaches.
Moreover, the bioinformatics analysis added an additional layer of information by mapping the
identified proteins to significantly over-represented GO categories and by identifying protein–protein




Quarter milk samples used in this study were collected from 11 dairy cows from the Elora
dairy research station at the University of Guelph. The cows were selected from the same herd and
breed, were in mid to late lactation, and ranged in age from 4 to 8 years to avoid the effect of these
confounding factors on the results. The criteria for selection of the cows were based on the results
of clinical examination (absence of systemic and local signs) to exclude clinical mastitis. Cows in
the control group had no previous history of clinical mastitis, had a low Somatic Cell Count (SCC),
and had negative cultures for S. aureus in the two months preceding the study, whereas cows in the
mastitic group had a previous history of subclinical mastitis, i.e., elevated SCC and positive bacterial
culture but no systemic or localized signs of mastitis and no history of major systemic diseases. The use
of all animals in this study was according to the guidelines of the Animal Care and Use Committee
of the University of Guelph. (AUP # 1424, Approved time line: Monday, 30 April 2012 to Monday,
11 July 2016). All milk samples were visibly normal in gross appearance. Quarter milk samples (30 mL)
were collected aseptically and brought immediately to the laboratory. Based on the Somatic Cell Count
(SCC) and bacterial culture results, the samples were divided into two groups—a control group and
a group with subclinical mastitis. Milk samples in the control group (n = 5) were microbiologically
negative for S. aureus and had a SCC of less than 2 × 105 cells/mL and the cows had no previous
history of clinical mastitis in the two months preceding the study. Milk samples in the mastitic group
(n = 6) were positive for S. aureus culture and had a high SCC of more than 2 × 105 cells/mL. Milk
samples for proteomic analysis were immediately mixed with a protease inhibitor cocktail (Roche
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Diagnostics GmbH, Mannheim, Germany), to minimize proteolysis and kept at −80 ◦C until further
analysis. Microbiological analysis and SCC were performed within 24 h of collecting the samples.
4.2. SCC and Microbiological Examination
SCC was determined using a commercial automated cell counter (DeLaval Cell Counter DCC,
Tumba, Sweden). The bacteriological analysis was performed according to the standard procedures
of the National Mastitis Council [51]. Briefly, a loopful of each quarter milk sample was plated
on Columbia Blood agar (CBA) supplemented with 5% sheep red blood cells, incubated at 37 ◦C,
and examined at 24 h and 48 h for evidence of bacterial growth. S. aureus bacteria were identified by
culture characteristic on selective media, gram-staining, and biochemical reaction [52]. The results
of microbiological examination and SCC of both control and subclinical mastitic groups are shown
in a supplemental table (Table S3). Bacterial cultures of milk samples from cows with subclinical
mastitis infected with S. aureus showed typical morphological and biochemical properties of S. aureus
including large, creamy hemolytic colonies on CBA, positive coagulase production within 18 h,
and sugar–alcohol fermentation.
4.3. Separation of Whey Proteins
Whole milk samples were firstly centrifuged at 3000× g at 4 ◦C for 30 min to skim the milk
and the fat layer was removed using a spatula. The remaining clear portion was transferred to
an ultracentrifuge tube (Beckman Coulter Thickwall polycarbonate, Mississauga, ON, Canada)
and centrifuged again in a Beckman Coulter benchtop ultracentrifuge (model LXL-TB-015BD) with
a Swinging-Bucket Rotor (SW 32.1) at a speed of 45,000× g at 4 ◦C for 30 min. Casein micelles were
pelleted in the sediment and the translucent supernatant forming the whey fraction was aliquoted
into Eppendorf tubes and stored at −80 ◦C for further analysis. The total protein concentration was
assessed in the whey fractions using the bicinchoninic acid assay (BCA) Protein Assay (BCA Protein
Assay kit, Pierce™, ThermoFischer Scientific, Markham, ON, Canada).
4.4. In-Solution Trypsin Digestion of Whey Proteins
A quantity of 10 µg of whey protein in control and mastitic samples was dissolved in 20 µL of
denaturation buffer (8 M urea, 50 mM Tris-HCl (pH 8). The following steps were carried out with
incubation at room temperature and gentle shaking. Reduction of disulfide bonds was done by adding
0.2 µL of 5 mM dithiothreitol in 50 mM of ammonium bicarbonate (pH 7.8) and incubated at 37 ◦C
for 1 h. For the alkylation step, iodoacetamide (0.4 µL) was added to a final concentration of 15 mM
and incubated for an additional 30 min in the dark at room temperature. The reaction was diluted
with three volumes of 50 mM Tris-HCl (pH 8) or 50 mM ammonium bicarbonate (pH 7.8) to allow
for trypsin digestion. Finally, trypsin (Promega, product no. V5280) was added and incubated with
the protein extracts overnight at 37 ◦C.
4.5. Liquid Chromatography and Tandem Mass Spectrometry (LC-MS/MS)
Following trypsin digestion, peptides were separated by on-line reverse-phase high-pressure
liquid chromatography and mass spectrometry (LC-MS) using a LTQ-Orbitrap Elite (linear ion
trap-orbitrap) hybrid analyzer outfitted with a nanospray source and EASY-SPRAY 1200 split free
nano-LC system (ThermoFischer Scientific). A 50 cm PepMap RSLC Easy-Spray column filled with
2 µm C18 beads was used in the HPLC (ThermoFischer Scientific). The resultant peptides were loaded
at a pressure of 800 BAR and eluted over 0–120 min at a rate of 250 nL/min using a 0–35% acetonitrile
gradient in 0.1% formic acid. In the mass spectrometer, one full MS Scan (400–1500 m/z) was performed
in the Orbitrap Elite with an automatic gain control (AGC) of 500,000, max ion time of 200 ms, and one
microscan, at a resolution of 240,000. Ten data-dependent MS/MS scans were performed in the linear
ion trap using the ten most intense ions at 35% normalized collision energy. MS and MS/MS scans
were done in parallel. For MS/MS scans, the AGC was 10,000 with a maximum ion injection time of
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100 ms. A minimum ion intensity of 1000 was required to trigger the MS/MS scan. Dynamic exclusion
was applied with a maximum exclusion list of 500, with one repeat count and a repeat duration of 8 s
and exclusion duration of 30 s.
4.6. Quantitative Proteomic Data Analysis
4.6.1. Protein Identification and Label-Free Quantification
The raw MS/MS data from all samples were imported into a freely available computational
proteomics platform, MaxQuant (version. 1.3.0.5, Max-Planck-Institute of Biochemistry, Martinsried,
Germany), for label-free relative quantification analysis. Proteins were identified using Bos taurus protein
reference proteomes (UniProt Proteome ID:UP000009136; last updated 10 May 2015) downloaded from
the UniProt Knowledgebase and imported into the MaxQuant-integrated Andromeda search engine.
Precursor mass accuracy of 7 ppm and MS/MS accuracy of 0.5 Da were performed during the main
search. For identification and quantification, variable modification methionine oxidation and N-terminal
acetylation and fixed modification cysteine carbamidomethylation were set for the search and enzyme
specificity was set for trypsin where a maximum of two missed cleavages of trypsin was allowed for
searching. The false discovery rate (FDR) for peptide–spectrum match and protein identification was
set to 1% and was determined using the reversed peptide sequences (target–decoy–search strategy)
to account for any false matches. At least one unique or “razor” peptide was required for protein
identification. The frequently observed contaminants were removed after being compared to the
Bos taurus reference proteome and MaxQuant contaminant list, where proteins were assigned to Bos
taurus such as keratin and serum albumin protein if they were of bovine origin. Following protein
identification, the intensity for each identified protein was calculated using peptide signal intensities
(MS1). Retention time alignment, label-free quantification, and MaxLFQ normalization were done as
described in the MaxLFQ label-free quantification method [53]. The (“match-between-runs”) feature in
MaxQuant was enabled to run the identification transfer protocol within the experimental replicates to
extract the quantification information across the replicates [53,54].
4.6.2. Statistical Analysis
Perseus version 1.4.1.3 (Max-Planck-Institute of Biochemistry, Martinsried, Germany), the freely
available software, was used to perform the statistical analysis wherein the LFQ protein intensities
from the MaxQuant analysis were imported and transformed to a logarithmic scale with base 2.
To obtain the quantitative data for all of the peptides in the samples, peak intensities from the whole
set of measurements were compared [53]. The missing values were replaced with 20—the value of
the lowest intensity—to compensate for the low signals of the low-abundant proteins. The statistical
significance analysis and quantification were performed by two-way Student’s t-test using Perseus
software. All proteins with a fold-change of at least 1.5 and FDR-adjusted (p < 0.05) were considered to
be differentially abundant between the experimental groups. FDR-adjusted (p < 0.05) was corrected
using the Benjamini–Hochberg multiple correction method. To further improve visualization and
interpretation of the differentially abundant proteins, a Heatmap was generated using Perseus software.
4.6.3. Gene Ontology (GO) Enrichment Analysis
To investigate the biological and potential clinical value of the identified differentially abundant
proteins, further analysis was performed using enrichment and functional annotation analysis. Proteins
were submitted to the Database for Annotation, Visualization, and Integrated Discovery (DAVID) v6.8
software with an updated knowledge base (available online: http://david.abcc.ncifcrf.gov) [55].
4.6.4. Pathway and Network Analysis
To evaluate the integration of differentially abundant proteins through direct (physical) or indirect
(functional) associations, we searched the STRING database for protein–protein interactions networks
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using the STRING v10.5 web-tool (Search Tool for the Retrieval of Interacting Genes/Proteins, (v10.5,
EMBL, Heidelberg, Germany) [56]. The PPI enrichment p-value is 0.000273 with the application of
a Fisher’s exact test followed by a correction for multiple testing. Each PPI in the STRING database is
assigned a confidence score that ranges between 0 and 1. Also, we further identified and analyzed
the enriched canonical pathways using ingenuity pathway analysis (IPA) software (v6.0, QIAGEN,
Redwood City, CA, USA) [57].
The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium
via the PRIDE (available online: http://proteomecentral.proteomexchange.org) [58] partner repository
with the dataset identifier PXD007516.
5. Conclusions
The study identified 90 proteins, 25 of which were differentially abundant between healthy and
mastitic dairy cows. The functional analyses of these proteins showed strong links to host defense
functions including pathogen-recognition, direct antimicrobial function, and the acute-phase response.
The potential utility of these proteins for developing a diagnostic tool for subclinical mastitis will require
further research and validation. Moreover, the comprehensive clinical, bacteriological, proteomic, and
bioinformatics data presented in this study reinforces the data that are already available in the literature
for comparison and validation purposes.
Supplementary Materials: Supplementary materials can be found at www.mdpi.com/1422-0067/19/1/78/s1.
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